HR 3290

The 340B Transparency Act aims to increase accountability and oversight of the 340B drug discount program, which provides discounted medications to certain healthcare providers serving vulnerable populations. This bill requires covered entities to report detailed information about their drug purchases and usage, including the number of patients receiving drugs under the program, cost savings achieved, and charity care expenses. It also mandates the Secretary of Health and Human Services to publish this data publicly and establish auditing procedures to ensure compliance.